Rocket Pharmaceuticals Stock Market Value
| RCKT Stock | USD 14.10 0.01 0.07% |
| Symbol | Rocket |
Rocket Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rocket Pharmaceuticals. If investors know Rocket will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rocket Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.73) | Return On Assets (0.34) | Return On Equity (0.59) |
The market value of Rocket Pharmaceuticals is measured differently than its book value, which is the value of Rocket that is recorded on the company's balance sheet. Investors also form their own opinion of Rocket Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rocket Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rocket Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rocket Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rocket Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rocket Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rocket Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Rocket Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rocket Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rocket Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Rocket Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Rocket Pharmaceuticals or generate 0.0% return on investment in Rocket Pharmaceuticals over 30 days. Rocket Pharmaceuticals is related to or competes with Uniqure NV, Rhythm Pharmaceuticals, Solid Biosciences, MeiraGTx Holdings, Vaxcyte, Larimar Therapeutics, and Syndax Pharmaceuticals. Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that fo... More
Rocket Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rocket Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rocket Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 21.07 | |||
| Value At Risk | (5.67) | |||
| Potential Upside | 6.59 |
Rocket Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rocket Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rocket Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Rocket Pharmaceuticals historical prices to predict the future Rocket Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | (0.18) |
Rocket Pharmaceuticals Backtested Returns
Rocket Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0897, which implies the firm had a -0.0897% return per unit of risk over the last 3 months. Rocket Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rocket Pharmaceuticals' Risk Adjusted Performance of (0.06), variance of 15.51, and Coefficient Of Variation of (1,148) to confirm the risk estimate we provide. The company holds a Beta of 1.92, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Rocket Pharmaceuticals will likely underperform. At this point, Rocket Pharmaceuticals has a negative expected return of -0.35%. Please make sure to check Rocket Pharmaceuticals' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Rocket Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Rocket Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Rocket Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rocket Pharmaceuticals price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Rocket Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 1.58 |
Rocket Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Rocket Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rocket Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Rocket Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Rocket Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rocket Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rocket Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rocket Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rocket Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Rocket Pharmaceuticals Lagged Returns
When evaluating Rocket Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rocket Pharmaceuticals stock have on its future price. Rocket Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rocket Pharmaceuticals autocorrelation shows the relationship between Rocket Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Rocket Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.